Parkside Financial Bank & Trust

Bank

Position in NKTR — Nektar Therapeutics

CIK 1455267 SAINT LOUIS, MO

Position in NKTR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$3,741

+$3,284 QoQ

Shares Held

+420.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Parkside Financial Bank & Trust holds $38,701,001 across 131 Biotechnology names. NKTR ranks #40 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	1,329,164	$36,817,842
2	VRTX	Vertex Pharmaceuticals Inc / Ma	735	$328,206
3	HALO	Halozyme Therapeutics, Inc.	4,890	$316,040
4	TECH	BIO-TECHNE Corp	3,722	$194,511
5	REGN	Regeneron Pharmaceuticals, Inc.	194	$149,891
6	MRNA	Moderna, Inc.	1,807	$91,794
7	DNTH	Dianthus Therapeutics, Inc. /DE/	1,050	$88,116
8	VKTX	Viking Therapeutics, Inc.	2,310	$75,167

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,741	52	-63.6%	Shares	Sole	2026-05-13
2022-09-30	$457	143	-90.6%	Shares	Defined	2022-11-01
2022-06-30	$5,753	1,514	+46.7%	Shares	Defined	2022-07-13
2022-03-31	$5,562	1,032	+20.3%	Shares	Defined	2022-05-13
2021-12-31	$11,591	858	+4415.8%	Shares	Defined	2022-03-01
2021-09-30	$341	19	-70.8%	Shares	Defined	2021-10-29
2021-06-30	$1,115	65	+30.0%	Shares	Defined	2021-08-06
2021-03-31	$1,000	50	+6.4%	Shares	Defined	2021-05-10
2020-09-30	$779	47	-11.3%	Shares	Defined	2020-11-06
2020-06-30	$1,227	53	-36.1%	Shares	Defined	2020-08-10
2020-03-31	$1,481	83	—	Shares	Defined	2020-05-05
No filing history on record for this holder in this stock.